Abstract-Administration of 3,4-methylenedioxymethamphetamine (4 × 20 mg/kg) to non-transgenic CD-1 mice caused marked depletion in dopamine, 3,4-dihydroxyphenylacetic acid and 5-hydroxytryptamine in the caudate-putamen. There were no significant changes in serotonergic markers in the hippocampus and frontal cortex. Homozygous and heterozygous copper/zinc superoxide dismutase transgenic mice show partial protection against the toxic effects of 3,4-methylenedioxymethamphetamine on striatal dopaminergic markers. In addition, 3,4-methylenedioxymethamphetamine injections caused marked decreases in copper/zinc superoxide dismutase activity in the frontal cortex, caudate-putamen and hippocampus of wild-type mice. Moreover, there were concomitant 3,4-methylenedioxymethamphetamineinduced decreases in catalase activity in the caudate-putamen and hippocampus, decreases in glutathione peroxidase activity in the frontal cortex as well as increases in lipid peroxidation in the frontal cortex, caudate-putamen, and hippocampus of wild-type mice. In contrast, administration of 3,4-methylenedioxymethamphetamine to homozygous superoxide dismutase transgenic mice caused no significant changes in antioxidant enzyme activities nor in lipid peroxidation.
3,4-methylenedioxymethamphetamine (MDMA, "Ecstasy") is a ring-substituted phenyl-isopropylamine that is related to both amphetamines and hallucinogens, such as mescaline 28 ( Fig. 1 ). Its entry into the brain may be through P-glycoprotein located in the blood-brain barrier. 26 MDMA has been reported to enhance empathy and to cause euphoria, anxiety, depression and paranoid disorders in human subjects. 2, 12, 34 Neurologic effects of MDMA include seizures with secondary anoxic events and associated oxidative damage to the brain. 30 Moreover, MDMA can cause decrements in cerebrospinal fluid 5-hydroxyindoleacetic acid (5-HIAA) and homovanillic acid (HVA), 27 and at high doses, this drug of abuse might also damage dopaminergic as well as serotonergic neurons in humans. 14 Administration of MDMA to animals elicits variable neurotoxic effects that depend on the species under study. 28 In rats 5, 15, 16, 24, 39, 42 and nonhuman primates 36, 37 MDMA can produce long-lasting toxic effects on serotonergic neurons. In contrast, injections of MDMA to mice caused striatal dopamine (DA) depletion without significantly affecting serotonergic systems, when the animals were killed three to eight days 24 or two weeks later. 7, 31 Moreover, large differences in sensitivity to the DA-depleting properties of MDMA have been reported among different strains of mice. 45 Although the cause of MDMA-induced neurotoxicity has not been fully determined, a number of possible scenarios have been put forward. For example, because direct infusion of MDMA into cerebroventricular space did not cause any toxicity, it was suggested that the neurodegenerative effects of the drug might be related to its metabolites. 29, 33, 40 This argument is supported, in part, by the demonstration that MDMA is metabolized into catechol and quinone metabolites. 29, 33, 40, 44 Further metabolism of these compounds could result in the formation of free radicals which might induce oxidative stress, and subsequent cellular damage. 13 Other possible mechanisms also include: (i) increased metabolism of DA released by MDMA; 13, 22, 38 and (ii) formation of DA metabolites such as 6-hydroxydopamine which is known to cause oxidative stress. 4, 11 The possible role of reactive oxygen species in MDMA-induced toxicity is further supported by our previous observations that transgenic mice that have high levels of the antioxidant enzyme copper/zinc superoxide dismutase (Cu/ ZnSOD) in the brain were protected against the acute lethal effects of MDMA 7 and against the subacute and long-term toxic effects of the drug on brain DA systems. 9 Thus, we reasoned that, if MDMA was indeed causing oxidative stress in the brain, it might perturb the activities of various antioxidant enzymes (Cu/ ZnSOD, catalase, glutathione peroxidase) which participate in a concerted collaboration with each other in order to protect the brain against oxidative damage. We also tested the possibility that MDMA injections might be associated with increased lipid peroxidation in the mouse brain. Finally, in order to try to relate the changes in enzymatic activities to the neurotoxic effects of MDMA, we also measured the effects of MDMA on monoamine levels in mice killed at similar time-points following administration of the drug. The data on the perturbations of antioxidant enzymes presented herein support the view that MDMA-induced toxicity may indeed occur via the production of reactive oxygen species.
EXPERIMENTAL PROCEDURES

Chemicals
Glutathione reductase and NADPH were obtained from Sigma Chemical (St Louis, MO). Reduced glutathione (GSH) and t-butyl hydroperoxide was from Aldrich Chemical (Milwaukee, WI). Hydrogen peroxide was procured from Fischer Scientific Co. (Fairlawn, NJ). SOD assay kit (Cat. No. 574600) and lipid peroxidation assay kit (Cat. No. 473634) were obtained from CalbiochemNovabiochem (San Diego, CA). All the other chemicals were of analytical grade quality.
Animals
Male heterozygous and homozygous SOD-transgenic (Tg) mice of strain 218/3 on a CD-1 background were used in these experiments. These animals carry the complete human Cu/ZnSOD gene and were produced as described previously. 17 They were obtained from a colony maintained at our Institute. Male non-transgenic CD-1 mice (non-Tg) (Charles River, Raleigh, NC), weighing 30-45 g, were used as the wild control. These mice have been used in several experiments in which we have tested the role of oxidative stress in the deleterious effects of various toxins. 4, 8 All animal use procedures were according to the NIH Guide for the Care and Use of Laboratory Animals and were approved by the local Animal Care Committee.
Drug administration and preparation of samples
Mice received doses of 20.0 mg/kg of MDMA or saline via the intraperitoneal route. MDMA was given at 2-h intervals for a total of four injections. Control mice received saline. Mice were killed 16 h later and their brains were rapidly removed. The frontal cortex (FC), caudate-putamen (CPu) and hippocampus were dissected out on ice and frozen immediately at Ϫ 70ЊC.
Analysis of monoamines and their metabolites
Brain regions were analysed for monoamines and their metabolites using high-performance liquid chromatography utilizing electrochemical detection at ϩ0.75 V as previously described. 3 In brief, individual samples were sonicated in 400-500 ml 0.1 M perchloric acid and centrifuged at 7200 g (12,000 r.p.m.) for 10 min. The supernatant (50 ml) was injected on to a 10 cm × 4.6 mm Spherisorb 3 mM ODS reverse-phase chromatography column (Thomson Instruments, Springfield, VA) in a mobile phase containing 0.1 M citric acid, 8% acetonitrile, 0.5 g/l octanesulfonic acid, 0.3% triethylamine, and 10 mM EDTA at a flow rate of 0.7 ml/min. DA and its metabolites 3,4-dihydroxyphenylacetic acid (DOPAC) and HVA, serotonin (5-HT), and S. Jayanthi et al. 5-HIAA were separated and detected in a single chromatogram and were quantified as relative peak areas versus the internal standard, 5-hydroxy Nv-methyltryptamine. The detection limit was 100 pg. Protein content was determined by the method of Lowry et al. 25 
Antioxidant enzyme activities
To quantify the antioxidant enzymes, Cu/ZnSOD, catalase and glutathione peroxidase (GSH-Px) activities, the samples were weighed and homogenized using a Teflon glass homogenizer in 10 volumes of appropriate buffer required for the specific enzyme assay.
Cu/Zn-SOD was measured using the Calbiochem's SOD-525 kit. The assay is based on the SOD-mediated increase in the rate of autoxidation of 5,6,6a,11b-tetrahydroxybenzo[c]-fluorene in aqueous alkaline solution to yield a chromophore with maximum absorbance at 525 nm. One enzyme unit is defined as the activity that doubles the autoxidation background. Catalase activity was quantitated from the decrease in the absorbance of H 2 O 2 at 240 nm in the presence of the enzyme. 10 One unit of catalase was defined as 1 mmol of H 2 O 2 consumed per minute per milligram protein. GSH-Px activity was quantitated from the decrease in NADPH absorbance at 340 nm using the method of Gunzler and Flohe. 19 The amount of GSH-Px inducing a net fall in GSH to 10% of the initial concentration in 1 min at 37ЊC and pH 7.0 is defined as one unit. Protein concentrations for calculation of specific activity were determined using Pierce BCA Protein assay kit (Rockford, Illinois) with bovine serum albumin as the standard and absorbance measured at 526 nm.
Lipid peroxidation
Lipid peroxidation was measured by the release of malondialdehyde (MDA), the end product derived from the breakdown of polyunsaturated fatty acids and related esters. 21 The LPO-586 assay kit from Calbiochem uses 10.3 mM Nmethyl-2-phenylindole in acetonitrile, a chromogenic reagent which reacts with MDA to yield a stable chromophore with maximal absorbance at 586 nm.
Data analysis
Data were analysed using statistical software (StatView 4.02) on a Macintosh computer (Quadra 700). Statistical analyses were done by a one-way ANOVA followed by Fischer's protected least significant difference (PLSD) test.
RESULTS
Effects of methylenedioxymethamphetamine on levels on striatal dopamine, 3,4-dihydroxyphenylacetic acid and homovanillic acid Figure 2 shows that administration of MDMA caused a significant reduction of DA (Ϫ78%) in the CPu of non-Tg mice. These changes were somewhat attenuated in the CPu of heterozygous (Ϫ51%) and homozygous (Ϫ45%) SOD-Tg mice (Fig. 2) . The CPu content of the major DA metabolite, DOPAC, was also reduced in the non-Tg control (Ϫ63%) and heterozygous SOD-Tg mice (Ϫ47%) but not in homozygous SOD-Tg mice (Fig. 2) .
Effects of methylenedioxymethamphetamine on levels of 5-hydroxytryptamine and 5-hydroxyindoleacetic acid in the brain Figure 3 shows that MDMA caused decreases in 5-HT levels in the CPu of non-Tg mice (Ϫ40%). 5-HT levels were not affected in the FC nor in the hippocampus of non-Tg mice. There were no significant changes in 5-HT levels in any of the brain regions of the heterozygous and homozygous SOD-Tg mice (Fig. 3A) . MDMA did not affect 5-HIAA levels in any of the strains of mice (Fig.  3B) . MDMA caused no changes in norepinephrine levels (data not shown).
Effects of methylenedioxymethamphetamine on antioxidant enzymes
Copper/zinc-superoxide dismutase activity. In comparison to non-Tg mice, heterozygous SOD-Tg mice showed a 2.1-fold increase while homozygous SOD-Tg mice showed a 4.threefold increase in SOD activity in the FC (Fig. 4) . In the CPu and hippocampus, heterozygous SOD-Tg mice showed respective increases of threefold and 2.8-fold while homozygous SOD-Tg mice demonstrated changes corresponding to 3.6-fold and threefold increases compared to control Cu/ZnSOD values (Fig. 4) .
Administration of MDMA caused significant decreases in enzyme activity in all three brain regions examined in the non-Tg mice (Fig. 4) . These corresponded to Ϫ85%, Ϫ55% and Ϫ65% in the FC, CPu and hippocampus, respectively. MDMA-induced decreases in SOD activity were attenuated in the FC (Ϫ40%), the CPu (Ϫ25%), and hippocampus (Ϫ30%) of heterozygous SODTg mice (Fig. 4) whereas MDMA caused no significant changes in SOD activity in the homozygous SOD-Tg mice (Fig. 4) .
Catalase activity. Catalase activity was significantly higher in the FC (1.8-fold), CPu (1.25-fold) and hippocampus (1.5-fold) of homozygous SODTg mice in comparison to the activity measured in non-Tg mice (Fig. 5) . Catalase activity was also slightly but significantly increased in the CPu (1.2-fold) and hippocampus (1.3-fold) of heterozygous SOD-Tg mice. MDMA caused significant decreases in catalase activity in both the CPu and hippocampus but not in the cortices of non-Tg and heterozygous SOD-Tg mice (Fig. 5 ) whereas there were no significant changes in catalase activity in the brains of homozygous SOD-Tg mice.
Glutathione peroxidase activity. GSH-Px activity was slightly but significantly increased in the CPu (1.2-fold) of homozygous SOD-Tg mice (Fig.  6) . MDMA treatment caused significant decreases only in the FC of the non-Tg mice (Fig. 6) . Unexpectedly, MDMA treatment led to increases in GSH-Px activity in all three brain regions of heterozygous and homozygous SOD-Tg mice.
Effects of methylenedioxymethamphetamine on lipid peroxidation
There were no differences in MDA released in saline-treated mice of the three strains. MDMA injections caused increased MDA release in the three brain regions of both non-Tg and heterozygous SOD-Tg mice (Fig. 7) . The percentage increases were more prominent in the non-Tg and consisted of respective increases of ϩ40% (FC), ϩ35% (CPu) and ϩ50% (hippocampus) in the non-Tg mice but of ϩ25% (FC), ϩ32% (CPu) and ϩ30% (hippocampus) in the heterozygous SOD-Tg mice. MDMA did not affect MDA release in the homozygous SOD-Tg mice (Fig. 7) .
DISCUSSION
The major MDMA effects reported here include: (i) neurotoxic effects on striatal dopaminergic terminals; (ii) decreases in Cu/ZnSOD activity in the FC, CPu and hippocampus regions of non-Tg mice; (iii) decreases in catalase activity in the CPu and hippocampus in non-Tg mice; (iv) decreases in GSH-Px MDMA, reactive oxygen species and toxicity 1383 In what follows, we discuss possible scenarios for these observations. It is to be noted that both catalase (Fig. 5 ) and GSH-Px (Fig. 6 ) activities are increased in the untreated SOD-Tg mice, with the greatest increases being observed in the FC of the animals. The fact that Cu/ZnSOD activity (Fig. 4) also showed greater percentage increases in the FC suggests that there might be a relationship between these observations. Specifically, because the high Cu/ZnSOD activity in the FC would generate more H 2 O 2 from the enzymatic breakdown of superoxide radicals, it is likely that the enzymes, catalase and GSH-Px responsible for the catabolism of H 2 O 2 , might have shown a much greater compensatory response in the FC compared to the CPu or the hippocampus.
The present data on the effects of MDMA on monoaminergic systems are in accord with previous observations reported in mice. 9 For example, a single large dose of MDMA caused decreases in DA but not in 5-HT levels 9 while multiple large doses of the drug caused only small and transient decreases in striatal 5-HT levels. 29 The present attenuation of the effects of MDMA in SOD-Tg mice is also consistent with data obtained previously. 9 In those experiments, a different schedule of MDMA injections was used. Specifically, one large dose (50 mg/kg) or three large doses given one day apart were used. In both cases, however, SOD-Tg mice showed a substantial degree of protection against the toxic effects of the drug. 9 Using a dose schedule similar to the one in the present study (20 mg/kg × 4), we also observed marked decreases in [ 125 I]-RTI-labeled DA uptake sites in non-Tg mice killed two weeks after MDMA administration; these were attenuated in SOD-Tg mice (unpublished observations). These observations indicate that the neurotoxicity of the MDMA may indeed be mediated, in part, by the increased production of superoxide radicals. As suggested in the introduction, superoxide anions (O 2 Ϫ ) might be produced as by-products of reactions that involve redox-cycling or through the autoxidation of excess DA released by MDMA. 11, 41 Interaction of H 2 O 2 with O 2 Ϫ could lead to the production of the more toxic hydroxyl radicals 1, 6, 20 with subsequent degeneration of the nigrostriatal dopaminergic pathway. Although formation of superoxide radicals 8, 32 and hydroxyl radicals 18 23 The protection afforded in the SOD-Tg mice support that view.
It is also of interest that injections of MDMA to heterozygous and homozygous SOD-Tg mice resulted in significant increases in GSH-Px in all the three brain regions examined (see Fig. 6 ). These observations suggest that these mice were able to increase their production of GSH-Px in order to get rid of excess H 2 O 2 generated from the dismutation of O 2 Ϫ formed subsequent to the administration of MDMA. The SOD-Tg mice might have been able to respond in that way because the GSHPx system in SOD-Tg mice was already primed to react because of the increased basal levels of H 2 O 2 being generated in SOD-Tg mice as previously reported. 35 The increase in lipid peroxidation observed in the present study replicates similar findings reported in a previous study in which one large dose (40 mg/kg) of MDMA was given to rats. 43 In that study, deprenyl which afforded protection against the toxic effects of MDMA also prevented the increases in lipid peroxidation. 43 These observations are consistent with our present demonstration that the MDMA-induced increase in lipid peroxidation is attenuated in SOD-Tg mice. Thus, concordant observations provide conclusive support for the idea that MDMA causes oxidative stress in mammalian brains.
CONCLUSIONS
The present paper documents, for the first time, the effects of toxic doses of MDMA on free radical scavenging enzymes in non-Tg and SOD-Tg mice. The effects of MDMA on these antioxidant enzymes and the increase observed in lipid peroxidation provide support for a role of a cascade of toxic events that appear to consist of the generation of superoxide radicals, hydrogen peroxide and hydroxyl radicals.
